LabGenius - Engineering new biological materials using synthetic DNA
Dr James Field and a group of fellow Imperial College London PhD students created spin-out company LabGenius in 2012 to commercialise their ground-breaking new technology: the ability to produce trillions of variations of gene sequences, which can be used to create new biological materials.
|$3.660M||Private investment secured by LabGenius|
|7||People employed by LabGenius|
|2017||Year Field won BBSRC Early Career Innovator of the Year|
|£102k||BBSRC investment to support the research|
The company uses artificial intelligence to predict which gene mutations will improve a biological design, enabling scientists to produce new therapeutics or advanced materials such as adhesives, catalysts and sensors.
LabGenius recently secured $3.66 million in private investment, employs seven people and has three contracts with Dstl to produce new defence materials, including improved body armour and adhesives.
Field features in American magazine Forbes’ 2018 list of the 600 most influential people in the world under age 30, and won BBSRC Early Career Innovator of the Year in 2017.
Read the full impact evidence report:
You may need to download additional plug-ins to open this file.